XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2

Stockholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2024

Defined Benefit Plan Disclosure [Line Items]

Schedule of restricted stock units

Schedule of restricted stock units
			Restricted Stock Units Outstanding								Weighted
			Number of				Weighted Average Grant – Date				Average Remaining life				Aggregate Intrinsic
			Units				Fair Value Price				(years)				Value
Outstanding, December 31, 2023				67,250			$	2.25				2.07			$	57,842
Granted				—				—				—				—
Exercised				—				—				—				—
Forfeited/canceled				(11,086	)			(2.25	)							(9,535	)
Outstanding, March 31, 2024				56,164			$	2.25				2.35			$	48,307

Twin Vee [Member]

Defined Benefit Plan Disclosure [Line Items]

Schedule of assumptions

Schedule of assumptions
			Three months ended
			March 31, 2024
			2024				2023
Expected term			5 years				4.94 - 5 years
Expected average volatility			27 - 46%				49 - 50%
Expected dividend yield			—				—
Risk-free interest rate			1.50 –4.45%				1.50 – 2.96%

Schedule of option activity

Schedule of option activity
			Options Outstanding								Weighted Average
			Number of Options				Weighted Average Exercise Price				Remaining life (years)				Grant Date Fair value of option
Outstanding, December 31, 2023				1,271,016			$	3.99				8.04				2,213,147
Granted				—				—				—				—
Exercised				—				—				—				—
Expired				(8,906	)			(2.73	)			—				(11,109	)
Forfeited/canceled				(25,695	)			(1.77	)			—				(18,929	)
Outstanding, March 31, 2024				1,236,415			$	4.04				3.75				2,183,109
Exercisable options, March 31, 2024				931,533			$	4.39				4.37

Forza [Member]

Defined Benefit Plan Disclosure [Line Items]

Schedule of assumptions

Schedule of assumptions
			Three Months Ended
			March 31,
			2024
Expected term			5 years
Expected average volatility			108 - 113%
Expected dividend yield			—
Risk-free interest rate			2.98 - 4.72%

Schedule of option activity

Schedule of option activity
			Options Outstanding								Weighted Average
			Number of				Weighted Average				Remaining life				Grant Date
			Options				Exercise Price				(years)				Fair value of option
Outstanding, December 31, 2022				1,441,500			$	3.41				0.05			$	4,009,913
Granted				518,000				0.70				9.76				287,835
Exercised				—				—
Forfeited/canceled				(69,583	)			1.24				9.62				(40,248	)
Outstanding, December 31, 2023				1,889,917			$	2.75				9.36			$	4,257,500
Granted				—				—				0
Exercised				—				—				0
Forfeited/canceled				(396,843	)			1.66				8.98				(69,413	)
Outstanding, Mach 31, 2024				1,493,074			$	2.75				8.78			$	4,188,087
Exercisable options, March 31, 2024				748,750			$	3.48				8.58

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_DefinedBenefitPlanDisclosureLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=VEEE_TwinVeeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=VEEE_ForzaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: